Irritable bowel syndrome (IBS) is an often misunderstood and underdiagnosed condition that affects about 15.3 million people in the United States.
No one remedy works for all patients, so there’s a great medical need to develop new therapies for IBS, Andrew Mulberg, M.D., a gastroenterologist with the Food and Drug Administration (FDA), said in one of the agency’s “Consumer Update” articles.